跳至主要内容
临床试验/NCT00680888
NCT00680888已完成不适用

Adherence in Adolescents and Children Treated on Quetiapine

AstraZeneca0 个研究点目标入组 30 人开始时间: 2005年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
30
主要终点
Survival analysis of rate of adherence to treatment on quetiapine

研究概览

简要总结

Observational study aimed to describe the adherence in a population of adolescents and children treated on quetiapine from a first psychotic episode whose more important secondary objective is to identify possible predictive factors influencing the adherence to treatment with Quetiapine

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
7 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • At least one psychotic symptom (delusions or hallucinations) before age
  • Start of treatment in a maximum period of 2 years after the onset of first psychotic symptom
  • Written informed consent by parents or guardians and patients.

排除标准

  • Pregnancy or lactancy
  • High risk of aggression or suicidal behaviour
  • Alcohol dependence

结局指标

主要结局

Survival analysis of rate of adherence to treatment on quetiapine

时间窗: 6 months

次要结局

  • Survival analysis of rate of adherence to treatment on quetiapine(12 months)
  • Clinical and sociodemographic parameters (CGI-C, CGI-Suicidal, PANSS, HDRS, YMRS, SDQ, DAS, GAF, SUMD) possibly influencing adherence(0, 6, 12 months)
  • Tolerability profile (UKU) possibly influencing adherence(0, 6, 12 months)

研究者

发起方
AstraZeneca
申办方类型
Industry

相似试验